Compare RLGT & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLGT | SLP |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | United States | United States |
| Employees | 1107 | N/A |
| Industry | Oil Refining/Marketing | EDP Services |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 416.9M | 371.9M |
| IPO Year | 2006 | 1996 |
| Metric | RLGT | SLP |
|---|---|---|
| Price | $8.69 | $18.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $8.00 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 302.9K | 143.1K |
| Earning Date | 05-08-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.43 | N/A |
| EPS | 0.39 | ★ 0.43 |
| Revenue | ★ $934,356,000.00 | $59,577,000.00 |
| Revenue This Year | $2.13 | $3.80 |
| Revenue Next Year | $5.18 | $5.90 |
| P/E Ratio | ★ $38.65 | $42.88 |
| Revenue Growth | 3.51 | ★ 10.52 |
| 52 Week Low | $5.82 | $11.09 |
| 52 Week High | $10.20 | $21.01 |
| Indicator | RLGT | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 51.14 | 63.18 |
| Support Level | $8.68 | $18.22 |
| Resistance Level | $8.77 | $18.46 |
| Average True Range (ATR) | 0.36 | 0.02 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 30.16 | 75.00 |
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services, including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.